Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13686 | 756 | 22.5 | 46% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
810 | 11347 | HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//HISTAMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CAS 76963 41 2 | Author keyword | 11 | 100% | 1% | 6 |
2 | MIFENTIDINE | Author keyword | 3 | 100% | 0% | 3 |
3 | HISTAMINE H 2 RECEPTORS | Author keyword | 2 | 25% | 1% | 6 |
4 | AMTHAMINE | Author keyword | 2 | 43% | 0% | 3 |
5 | NIZATIDINE | Author keyword | 2 | 12% | 2% | 12 |
6 | HISTAMINE H2 RECEPTORS | Author keyword | 1 | 40% | 0% | 2 |
7 | H2 RECEPTORS | Author keyword | 1 | 33% | 0% | 2 |
8 | ABDOMINIS MUSCLE | Author keyword | 1 | 50% | 0% | 1 |
9 | EXPT TOXICOL PHARMACOL | Address | 1 | 50% | 0% | 1 |
10 | H 1 AND H 2 BLOCKERS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CAS 76963 41 2 | 11 | 100% | 1% | 6 | Search CAS+76963+41+2 | Search CAS+76963+41+2 |
2 | MIFENTIDINE | 3 | 100% | 0% | 3 | Search MIFENTIDINE | Search MIFENTIDINE |
3 | HISTAMINE H 2 RECEPTORS | 2 | 25% | 1% | 6 | Search HISTAMINE+H+2+RECEPTORS | Search HISTAMINE+H+2+RECEPTORS |
4 | AMTHAMINE | 2 | 43% | 0% | 3 | Search AMTHAMINE | Search AMTHAMINE |
5 | NIZATIDINE | 2 | 12% | 2% | 12 | Search NIZATIDINE | Search NIZATIDINE |
6 | HISTAMINE H2 RECEPTORS | 1 | 40% | 0% | 2 | Search HISTAMINE+H2+RECEPTORS | Search HISTAMINE+H2+RECEPTORS |
7 | H2 RECEPTORS | 1 | 33% | 0% | 2 | Search H2+RECEPTORS | Search H2+RECEPTORS |
8 | ABDOMINIS MUSCLE | 1 | 50% | 0% | 1 | Search ABDOMINIS+MUSCLE | Search ABDOMINIS+MUSCLE |
9 | H 1 AND H 2 BLOCKERS | 1 | 50% | 0% | 1 | Search H+1+AND+H+2+BLOCKERS | Search H+1+AND+H+2+BLOCKERS |
10 | HEXOBARBITAL INDUCED SLEEPING TIME | 1 | 50% | 0% | 1 | Search HEXOBARBITAL+INDUCED+SLEEPING+TIME | Search HEXOBARBITAL+INDUCED+SLEEPING+TIME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NONINVASIVE HEMODYNAMIC MEASUREMENTS | 10 | 73% | 1% | 8 |
2 | H2 ANTAGONIST THERAPY | 3 | 100% | 0% | 3 |
3 | INTRAVENOUS CIMETIDINE | 3 | 33% | 1% | 7 |
4 | IMPROMIDINE | 2 | 36% | 1% | 5 |
5 | MIFENTIDINE | 2 | 67% | 0% | 2 |
6 | GASTROPROKINETIC ACTIVITY | 1 | 38% | 0% | 3 |
7 | H 3 TIOTIDINE | 1 | 50% | 0% | 2 |
8 | NIZATIDINE | 1 | 11% | 1% | 7 |
9 | POSTPARTUM PATIENTS | 1 | 33% | 0% | 2 |
10 | ACTIVE DUODENAL ULCERS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Cardiac histamine receptors: Their pharmacological consequences and signal transduction pathways | 1999 | 17 | 56 | 59% |
HEMODYNAMIC-EFFECTS OF H-2-RECEPTOR ANTAGONISTS | 1992 | 10 | 37 | 81% |
HISTAMINE AND CARDIAC-ARRHYTHMIAS | 1986 | 157 | 50 | 40% |
CLINICAL ASPECTS OF CARDIOVASCULAR EFFECTS OF H-2-RECEPTOR ANTAGONISTS | 1995 | 9 | 54 | 83% |
CARDIOVASCULAR EFFECTS OF HISTAMINE WITH SPECIAL REFERENCE TO CARDIAC SIDE-EFFECTS OF H2-RECEPTOR-ANTAGONISTS | 1989 | 17 | 47 | 62% |
HISTAMINE-H2-RECEPTOR ANTAGONISTS AND THE CARDIOVASCULAR-SYSTEM | 1993 | 2 | 36 | 72% |
CARDIOVASCULAR SIDE-EFFECTS OF H-2-RECEPTOR ANTAGONISTS | 1994 | 0 | 27 | 93% |
Prokinetic activity of nizatidine: Implications for the management of patients with gastroesophageal reflux disease | 1999 | 6 | 17 | 35% |
Data Mining as a Powerful Tool for Creating Novel Drugs in Cardiovascular Medicine: The Importance of a "Back-and-Forth Loop" Between Clinical Data and Basic Research | 2015 | 0 | 32 | 31% |
ACTIONS OF CIMETIDINE AND RANITIDINE AT SOME CHOLINERGIC SITES - IMPLICATIONS IN TOXICOLOGY AND ANESTHESIA | 1986 | 41 | 21 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT TOXICOL PHARMACOL | 1 | 50% | 0.1% | 1 |
2 | MED MOL PHYSIOL BIOL PHYS | 0 | 33% | 0.1% | 1 |
3 | PHARMACOCHEM LEIDEN AMSTERDAM DRUG | 0 | 33% | 0.1% | 1 |
4 | GATA ACIL TIP AD | 0 | 25% | 0.1% | 1 |
5 | EMERGENCY ROOM MED | 0 | 13% | 0.1% | 1 |
6 | ST PAULS HOSP PULM | 0 | 11% | 0.1% | 1 |
7 | CANAKKALE PUBL HOSP | 0 | 100% | 0.1% | 1 |
8 | CARDIOVASC MED DEV | 0 | 100% | 0.1% | 1 |
9 | DE SURG RADIOL SCI | 0 | 100% | 0.1% | 1 |
10 | DENT ODONTOL ARARAQUARA UNESP FOAR | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160730 | HEIDELBERG CAPSULE//ROXATIDINE ACETATE//SECT PEDIAT CLIN PHARMACOL TOXICOL |
2 | 0.0000133776 | HVIDOVRE HOSP ENDOCRINOL//E170//MALE SEXUAL HLTH |
3 | 0.0000128422 | ARPROMIDINE//HISTAMINE H 2 RECEPTOR AGONISTS//IMPROMIDINE |
4 | 0.0000118557 | ALLERGIC ANGINA//ALLERGIC MYOCARDIAL INFARCTION//KOUNIS SYNDROME |
5 | 0.0000104856 | AGONIST AFFINITY//OPERATIONAL MODEL OF AGONISM//IRREVERSIBLE RECEPTOR INACTIVATION METHOD |
6 | 0.0000098068 | SUCRALFATE//PEPTIC ULCER THERAPY//DE NOL |
7 | 0.0000097927 | DANISH ANAESTHESIA ALLERGY//COMPLICATIONS ANAPHYLAXIS//POLE URAD |
8 | 0.0000074617 | HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//H 3 RECEPTOR |
9 | 0.0000071722 | HYPOTYROIDISM//LIBERINS//UNSOLVABLE PROBLEMS |
10 | 0.0000053709 | CISAPRIDE//KW 5092//CINITAPRIDE |